+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient

Physics in Medicine and Biology 58(4): 807-823

Pediatric patients who received radiation therapy are at risk of developing side effects such as radiogenic second cancer. We compared proton and photon therapies in terms of the predicted risk of second cancers for a 4 year old medulloblastoma patient receiving craniospinal irradiation (CSI). Two CSI treatment plans with 23.4 Gy or Gy (RBE) prescribed dose were computed: a three-field 6 MV photon therapy plan and a four-field proton therapy plan. The primary doses for both plans were determined using a commercial treatment planning system. Stray radiation doses for proton therapy were determined from Monte Carlo simulations, and stray radiation doses for photon therapy were determined from measured data. Dose-risk models based on the Biological Effects of Ionization Radiation VII report were used to estimate the risk of second cancer in eight tissues/organs. Baseline predictions of the relative risk for each organ were always less for proton CSI than for photon CSI at all attained ages. The total lifetime attributable risk of the incidence of second cancer considered after proton CSI was much lower than that after photon CSI, and the ratio of lifetime risk was 0.18. Uncertainty analysis revealed that the qualitative findings of this study were insensitive to any plausible changes of dose-risk models and mean radiation weighting factor for neutrons. Proton therapy confers lower predicted risk of second cancer than photon therapy for the pediatric medulloblastoma patient.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052242328

Download citation: RISBibTeXText

PMID: 23322160

DOI: 10.1088/0031-9155/58/4/807

Related references

A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. RadioTherapy and Oncology 113(1): 84-88, 2014

SU-E-T-257: Risk of Radiogenic Second Cancer after Photon and Proton Craniospinal Irradiation. Medical Physics 39(6part13): 3762-3962, 2012

Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Physics in Medicine and Biology 54(8): 2259-2275, 2009

Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatric Hematology and Oncology 35(4): 257-267, 2018

A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma. Acta Oncologica 56(8): 1031-1042, 2017

Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiation Oncology 7: 116, 2012

Effects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma. Advances in Radiation Oncology 2(2): 220-227, 2017

Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation. Cancers 7(1): 407-426, 2015

Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncologica 50(6): 806-816, 2011

Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. International Journal of Radiation Oncology Biology Physics 81(3): 637-646, 2011

Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea. World Journal of Pediatrics 13(4): 367-373, 2017

Ro-20A Planning Approach For Lens Sparing Proton Craniospinal Irradiation In A Pediatric Patient. Neuro-Oncology 18(Suppl 3): iii163.3-iii163, 2016

Reducing Stray Radiation Dose for a Pediatric Patient Receiving Proton Craniospinal Irradiation. Nuclear Technology 168(1): 108-112, 2009

Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatric Blood and Cancer 65(8): E27095, 2018

Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. International Journal of Radiation Oncology Biology Physics 86(2): 277-284, 2013